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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comincreased in the bifurcation group. However the overall rate of deﬁnite or probable ST
was similar (1.4% vs. 0.7%, p¼0.08). Of the 7 cases of ST in the bifurcation sub-
group, 6 occurred in patients treated with a 2 stent strategy.
Conclusions: These preliminary results suggest that BES’s perform well in bifurca-
tion lesions and that ST seems to be inﬂuenced by the stenting strategy.
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Background: The coronary bifurcation lesions are still problematic issue in inter-
ventional cardiology and their occurrence is a marker of increased procedural and
long-term risk. The aim of present study was to compare clinical effectiveness and
safety of newest version of BiOSS stent – BiOSS Lim, in comparison with historical
version, covered with paclitaxel, BiOSS Expert.
Methods: From September 2009, all patients with coronary bifurcation lesions
deemed appropriate for implantation of dedicated bifurcation stent BiOSS (Bifurcation
Optimization Stent System, Balton, Poland) were included in prospective registry. The
patients were excluded if they had ST-segment elevation myocardial infarction
(STEMI), life expectancy less than one year, inability to take double antiplatelet
therapy for 12 months, with bifurcation lesions Medina 001 and patient requiring more
than one BiOSS stent implantation. All patients had clinical examination at 30 days
and every 3 months thereafter were contacted by phone call.
Results: A 106 patients were included - 80 patients with BiOSS Lim (sirolymus-
eluting) and 26 with BiOSS Expert (paclitaxel-eluting). The mean age was 6410,
71% males, 39% diabetics, 35% had previous MI, 43% had previous PCI, 13%
previous CABG. Most of the patients were in CCS class 3-4 or were unstable (68%).
Multivessel disease or left main distal bifurcation occurred in 76%. True bifurcation
lesions occurred in 51% (Medina xx1). There were 2 postprocedural myocardial in-
farctions (1.9%) (CK-MB elevation). Increase of tropoinin I >3xnormal was observed
in 18%. At mean follow-up of 12 months there were 2 deaths (2%) and 3 spontaneous
myocardial infarctions (2.8%). A 12 angiographic restenotic lesions were detected
(11.3%), of which 10 (9.4%) were treated by repeat angioplasty. In total, the rate of
major adverse cardiac events (death, myocardial infarction and repeat PCI) was 10.4%
(11 pts). The rate of TLR (5%) and MACEs (7.5%) with BiOSS Lim was signiﬁcantly
lower than in BiOSS Expert (p< .005)
Conclusions: The new sirolymus eluting dedicated coronary bifurcation stent BiOSS
Lim demonstrated marked superiority over its paclitaxel version, with excellent
clinical efﬁcacy and safety in mid-term follow-up.Coronary Lesions - CTO
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Background: Chronic total occlusion (CTO) represents one of the most challenging
lesion subset in interventional cardiology. The Italian Registry of Chronic Total Oc-
clusion (IRCTO) aims to provide current data on CTO prevalence, and on clinical and
angiographic characteristics and management of CTO patients. Moreover, it reports
the effect of CTO treatment strategy on long-term prognosis.
Methods: The IRCTO is a prospective real world multicentre registry, which enrolled
patients showing at least 1 CTO at coronary angiography in thirteen high volume
catheterization labs across Italy. Clinical and angiographic data of all CTO patients,
regardless of chosen treatment strategy (medical therapy [MT], percutaneous coronaryB56 JACC Vol 64/11/Suppl Bintervention [PCI], or coronary artery bypass grafting [CABG]), were collected into a
web database.In order to compare outcomes of patients undergoing different treatment
strategies, while minimizing the impact of treatment selection bias and potential
confounding, a rigorous adjustment by propensity score matching (PSM) was
performed.
Results: A total of 1,777 patients were enrolled, among these 826 (46,5%) patients
were managed by MT, 776 (43,7%) by PCI and the last 175 (9.8%) were referred to
CABG. At one year, patients undergoing successful PCI showed lower rate of
MACCE and cardiovascular death in comparison with patients treated with MT and
CABG (2.6% vs 8.2% and vs 6.9%, p< 0.001 and p< 0.01, and 1.4% vs 4.7% and vs
6.3%, p< 0.001 and p< 0.001 respectively). After PSM analysis patients treated with
PCI showed lower incidence of death, acute myocardial infarction and re-hospitali-
zation rate in comparison with MT (4.4% vs 1.5% p< 0.001, 2.9% vs 1.1% p¼0.03
and 4.4% vs 2.3% p¼0.04 respectively).
Conclusions: The present study provides current data on prevalence, characteristics
and management of CTO patients. More importantly, our data showed as percuta-
neous revascularization of a CTO leads to a signiﬁcantly improved survival rate and a
reduction in MACCE at 1-year follow-up in comparison with MT and/or CABG
management.
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Background: Clinical beneﬁt of successful chronic total occlusion (CTO) revascu-
larization by percutaneous coronary intervention (PCI) remains under discussion. This
study aimed to assess health-related quality of life (HRQL), functional status and
myocardial ischemia after successful CTO PCI.
Methods: Between 2012 and 2014, 106 eligible patients who were scheduled for PCI
of a true CTO were included in this prospective study. HRQL questionnaire, six-
minute walk test and CMR studies were plan to be performed before and at 6-month
follow-up of patients with successful PCI of CTO. HRQL, was assessed by the short
form 36-item (SF-36) health survey, which measure health across eight-dimension,
including physical and mental components. Functional status was assessed by the six-
minute walk test. Regarding CMR study, the severity of ischemia was assessed by
means of an ischemic score index (ISI) based on the 16-segment model of analysis of
the left ventricle and calculated from the following items (relative weight is given in
brackets): 1) extension of the defect (20%); 2) persistence along the duration of the
perfusion sequence (20%); 3) transmurality (20%); and 4) inducibility of contractile
regional dysfunction under adenosine (40%).
Results: CTO recanalization signiﬁcantly improved all the components of the HRQL
test during follow-up (n¼66): patients with successful procedure experienced less
physical activity limitation (p< 0.001), rarer general pain episodes (p< 0.001) and
greater mental aspects (p< 0.001). The distance walked in the six-minute test (n¼59)
improved at follow-up (405.4  115.3 pre-PCI vs. 451.4  106.2 meters post-PCI, p<
0.001. Post-PCI, chest pain episodes decreased after the six-minute test, p< 0.001. A
correlation was found between distance walked in the six-minute test and physical
components of HRQL, r¼0.58, p< 0.001. Finally, total ISI by CRM (n¼37) also
improved signiﬁcantly, after PCI (basal 20.5 9.9% vs. post-PCI 4  9.2, p< 0.001).
Conclusions: CTO recanalization leads to a reduction in inducible myocardial
ischemia assessed by CMR. Furthermore, patients signiﬁcantly improved health-
related quality of life and experienced less physical activity limitation, and chest pain
episodes.
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Background: Chronic total occlusion (CTO) percutaneous coronary intervention
(PCI) can provide signiﬁcant clinical beneﬁts, yet there is limited information on its
success and safety in unselected patient populations. We sought to describe
contemporary frequency, predictors, and outcomes of CTO PCI in the United States.
Methods: We analyzed the frequency and outcomes of CTO PCI compared to non-
CTO PCI in elective patients, and of successful vs. failed CTO PCI, between July 1
2009 and March 31 2013 in the NCDR CathPCI Registry. Generalized estimatingj September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
True Lumen
(n¼154
lesions)
Subintimal
Stenting{
(n¼19 lesions) p value
Qualitative Findings:
Subintimal GW tracking, n (%)* 33(21.1) 19 (100) <0.001
Dissection Flap, n (%) 64 (41.6) 16 (84.2) <0.001
Dissected segment location
Proximal, n (%) 27 (17.5) 9 (47.4)
Distal, n (%) 24 (15.6) 5 (26.3) 0.003
Body, n (%) 13 (8.4) 2 (10.5)
Coronary Hematoma, n (%) 17 (11) 6 (32) 0.01
Calciﬁcation (>30o arc), n (%) 141 (92) 16 (84) 0.29
Calciﬁcation morphology
Superﬁcial, n (%) 98 (64) 7 (37) 0.02
Deep, n (%) 43 (28) 9 (47) 0.08
Quantitative Findings:
Dissection length, mm 5.4 (4 to 9) 4.2 (3 to 8.5) 0.27
Maximum arc of calcium,o 274  132 150  106 0.68
Proximal reference EEM CSA, mm2 15.7  4.4 14.4  3.6 0.2
Proximal reference lumen CSA, mm2 9.7  2.9 8.2  2.3 0.03
Distal reference EEM CSA, mm2 8.2  3.3 7.2  2.2 0.08
Distal reference lumen CSA, mm2 5.3  2 5.1  2 0.74
Post-Stent IVUS measurements:
Mean stent CSA, mm2 6.9  1.9 6.7  2.3 0.71
Stent Expansion 0.87  0.32 0.92  0.30 0.55
Stent symmetry index 0.89  0.02 0.92  0.086 0.23
Values are mean  SD, median (interquartile range), or n (%).
CSA indicates cross-sectional area; EEM, external elastic membrane; IVUS, intravascular
ultrasound.* immediately after wiring or after pre-dilation with a 1 to 2.0-mm balloon.{ ﬁnal
guidewire position in a false lumen with subsequent stent deployment in subintimal space.
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMequations logistic regression modeling was used to generate independent variables
associated with procedural success and procedural complications.
Results: During the study period, CTO PCI represented 3.8% of the total PCI volume
for stable coronary artery disease (22,365 of 594,510). Overall, patients undergoing
CTO PCI required higher contrast volume and ﬂuoroscopy time and had lower
procedural success (59% vs. 96%, P< 0.001) and higher MACE rate (1.6% vs. 0.8%,
P< 0.001) than non CTO patients. On multivariable analysis, several parameters
(including older age, current smoking, prior MI, prior CABG, prior peripheral arterial
disease, prior cardiac arrest, right coronary artery CTO target vessel, and less operator
experience), were associated with lower likelihood of CTO PCI procedural success,
while operators’ annual CTO PCI volume was associated with improved success
without signiﬁcant increase in major complications.
Conclusions: CTO PCI is currently performed infrequently in the US for stable
coronary artery disease and is associated with lower procedural success and higher
complication rates compared with non-CTO PCI. Procedural success was associated
with several patient factors and operator experience.
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Background: The recanalization success rate of chronic total coronary occlusions
(CTO-PCI) can be increased by a retrograde approach. The impact of the retrograde
compared to the antegrade PCI on long-term outcome is unknown. Aim of the study
was to evaluate the long-term MACCE rate (death, myocardial infarction, coronary
bypass surgery and stroke) in patients after retrograde versus antegrade CTO-PCI.
Methods: In a prospective study from January 2008 to June 2012 436 consecutive
patients with CTO’s ( 3 months old) were enrolled.
Results:Mean age was 63.4  10.3 years, 86% were male. The retrograde PCI, which
was used only after a failed antegrade intervention, was performed in 18 % (n¼79) of
patients. Patients with retrograde CTO-PCI had more frequently previous bypass
surgery, RCA as target vessel (79.7% vs. 56%.8, p< 0.0004), longer lesion length (46
vs. 30 mm, p< 0.001), longer procedure duration (108.2 vs. 63.2 min, p< 0.0001),
higher contrast volume (433.6 vs. 267.6 ml, p< 0.0001), longer ﬂuoroscopy time
(61.2 vs 30.1 min, p< 0.0001) and higher radiation exposure (285.3 vs. 145,0
Gycm2m p< 0.0001). Long-term overall MACCE rate (mean follow up 590  461
days) was not different after retrograde vs. antegrade CTO-PCI (14.3% vs. 15.1 %).
Same was true for the components of MACCE (death 5.7 vs. 8.5%, myocardial
infarction 2.8 vs. 2.6%, bypass surgery 8.6 vs. 5.3%, stroke 0 vs. 2.6%). However,
patients with failed antegrade PCI had a signiﬁcantly higher long-term MACCE rate
compared to successful antegrade PCI (29.2 vs. 12.5%, p< 0.04), whereas the MACCE
rate of failed vs. successful retrograde PCI was not different (14.3 vs. 14.3%).
Conclusions: Despite more patients with previous coronary bypass surgery and more
complex target lesions and procedures the overall long-term MACCE rate after
retrograde CTO-PCI is not different to antegrade CTO-PCI. Why the long-term
MACCE rate is higher only after failed vs. successful antegrade but not after failed vs.
successful retrograde CTO-PCI deserves further studies.
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Background: We evaluated the in-hospital and the long-term clinical and angio-
graphic outcomes of drug-eluting stents (DES) deployed in true versus false lumen of
successfully crossed chronic total occlusions (CTO)
Methods: Between August 2011 and October 2012, 157 consecutive patients with
173 CTO lesions were successfully recanalized in a single center. All procedures were
guided with intravascular ultrasound (IVUS). After successful guidewire crossing,
lesions were classiﬁed according to IVUS evaluation into 2 groups; (1) true lumen
group and, (2) subintimal stenting group; and compared with regards to in-hospital
and long term clinical outcomes
Results: In 154 lesions, DES were deployed in the true lumen; and in 19 (11%) le-
sions, DES were deployed in the subintimal space (95% conﬁdence interval: 6.3% to
15.6%) with a success rate of 96 % and 82.4%, in antegrade and retrograde ap-
proaches, respectively. IVUS showed that the prevalence of dissection was two times
and intramural hematoma (IMH) was three times as higher in the subintimal stenting
group (p< 0.001 and p< 0.01, respectively).Subintimal stenting was associated with a
signiﬁcant increase in minor perforations 6/19 (31.6 % vs. 8.4%, p¼0.002), all were
managed conservatively. Kaplan-Meier analysis revealed a similar rates of binary
restenosis and target lesion revascularization between groups (p¼0.73 and p¼0.97,
respectively).Six patients (4.6%, 6 / 129 patients) in the true lumen group and none in
the subintimal group died at one yearJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/CoIVUS FindingsConclusions: Subintimal stent deployment in CTO segments, using second generation
DES with IVUS guidance, carries a similar success rate and long-term angiographic
and clinical outcomes as true lumen stenting
TCT-195
Transradial Approach for Coronary Chronic Total Occlusion Interventions:
Insights from a Contemporary Multicenter Registry
Khaldoon Alaswad1, Rohan V. Menon2, Georgios Christopoulos2,
William Lombardi3, Dimitri Karmpaliotis4, J. Aaron Grantham5, Steven Marso5,
R. Michael Wyman6, Nagendra R. Pokala2, Siddharth M. Patel2, Anna Kotsia2,
Bavana V. Rangan2, Nicholas Lembo7, David Kandzari7, James Lee7,
Kalynych Anna7, Harold Carlson7, Santiago Garcia8, Craig Thompson9,
Subhash Banerjee2, Emmanouil Brilakis2
1Appleton Heart Institute, Appleton, WI, 2VA North Texas Health Care System and UT
Southwestern Medical Center, Dallas, TX, 3Peacehealth St. Joseph Medical Center,
Bellingham, WA, 4Columbia University Medical Center, New York, NY, 5Mid America
Heart Institute, Kansas City, MO, 6Torrance Memorial Medical Center, Torrance,
CA, 7Piedmont Heart Institute, Atlanta, GA, 8University of Minnesota and
Minneapolis VA Medical Center, Minneapolis, MN, 9Yale University School of
Medicine, New Haven, CT
Background: Transradial access is often used in percutaneous coronary inter-
vention(PCI) for chronic total occlusions (CTO), however, its efﬁcacy and safety in
this setting have received limited study.
Methods: We compared the technique and outcomes of transradial vs. transfemoral
access among 650 CTO PCI cases performed between January 2012 and March 2014
at 6 US centers.
Results: Most patients were men (87%) with high frequency of diabetes mellitus
(42%) and prior coronary artery bypass graft surgery (36%). The CTO target vessel
was the right coronary (59%), left anterior descending (20%), or circumﬂex (17%)
artery. TR access was used in 110 (17%) of the 650 cases, as follows: bilateral radial
access (63%); bilateral radial access plus unilateral or bilateral femoral access (7%);
unilateral radial access plus unilateral or bilateral femoral access (26%); and unilateral
radial access (4%). Six and eight French guide catheters were used through the radial
and femoral artery, respectively. Compared to transfemoral, transradial cases had
similar technical (92.6% vs. 93.0%, p¼0.87) and procedural (91.1% vs. 90.0%,
p¼0.95) success and major complication rates (1.7% vs 1.8 %, p¼0.99). However,
transradial access was associated with higher mean procedure (14283 vs. 12060
min, p¼0.008) and ﬂuoroscopy (5840 vs. 4931 min, p< 0.026) time, and number
of crossing approach changes (0.71.0 vs. 0.50.7, p¼0.008).ronary Lesions - CTO B57
